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Abstract: To clarify the role of tumor necrosis factor
(TNF)-a on osteoblast functions in the presence of metal
particles, two human osteoblast-like cell lines (MG-63 and
SaOS-2) were cultured with TNF-a in the presence or ab-
sence of titanium particles in vitro. A combination of TNF-a
and titanium particles showed additive effects on inhibition
of cell proliferation and alkaline phosphatase production.
On the other hand, production of interleukin-6, which is
well known to induce osteoclastogenesis and to directly
stimulate bone resorption, was additively stimulated by the
combination of TNF-a and titanium particles. These results
suggest that the association of TNF-a and titanium particles
may play an important role in the pathogenesis of peripros-
thetic osteolysis through two different pathways: a reduced
periprosthetic bone formation due to inhibition of osteoblast
proliferation and alkaline phosphatase production, and os-
teoblast-mediated activation of osteoclastic bone resorption
as suggested by the enhancement of interleukin-6 produc-
tion. © 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 52,
382–387, 2000.
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INTRODUCTION
Periprosthetic osteolysis and implant loosening af-
ter joint arthroplasty in both cemented and cementless
prostheses remain major causes of implant failure.
One cause of implant loosening is the proliferation of
a fibrous tissue surrounding the implant in which
macrophages phagocytosed wear debris.1,2 Moreover,
the interaction of particle wear debris with phagocytic
cells results in the activation of cells which in turn
produce mediators that provoke a cascade of osteo-
lytic events.3–9 Among the osteolytic modulators, tu-
mor necrosis factor (TNF)-a stimulates the osteoblasts
to produce bone resorptive mediators, interleukin
(IL)-6 and prostaglandin E2 (PGE2).
7,10
The fibrous tissue also provides an excess of wear
particles in the periprosthetic space.11 Direct interac-
tions between particles and bone cells are then pos-
sible. This fact is important because it has been shown
that particles could influence the functions of osteo-
blasts. After osteoblast-like cells (MC3T3-E1) and rat
osteosarcoma cells (17/2.8) phagocytosed particles of
hydroxyapatite, reduced cell growth and alkaline
phosphatase activity were measured.12 Biosynthesis of
both type-I and type-III collagen was decreased in the
human osteoblast-like cell (MG-63) and human osteo-
sarcoma cells, that had been treated with titanium (Ti)
particles.13 Poly(methyl methacrylate) (PMMA) par-
ticles were also shown to inhibit osteoblast prolifera-
tion and collagen synthesis, whereas osteocalcin and
IL-6 production were stimulated.14
Despite that the presence of wear particles in con-
junction with cytokines seems a common trend in
periprosthetic tissue, few data reflecting this situation
are available for osteoblasts. We hypothesized that cy-
tokines released by macrophages may alter the func-
tional modulation of osteoblastic cells caused by wear
particles. We then investigated the effect of TNF-a, a
representative cytokine released by macrophages, on
osteoblast-like cell functions in the presence or ab-
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sence of Ti particles in vitro. We showed that TNF-a
and Ti particles have additive effects on the inhibition
of osteoblast proliferation and alkaline phosphatase
(ALP) production. This additive stimulation in osteo-
blast was also measured for the production of IL-6,
which is well known to induce osteoclastogenesis and
to directly stimulate bone resorption.
MATERIALS AND METHODS
Cells
Human osteoblast-like cell lines MG-63 and SaOS-2
(American Type Culture Collection, Rockville, MD) were
grown in Dulbecco’s modified eagle’s medium (Irvine Sci-
entific, Santa Ana, CA) supplemented with 10% fetal bovine
serum (Irvine Scientific), L-glutamate (4 mM), penicillin (100
U/mL), streptomycin (100 mg/mL), and fungizone (0.25 mg/
mL) (Biowhittaker, Walkersville, MD), at 37°C and 5% CO2
in a humidified atmosphere. These cell lines display typical
phenotypes of osteoblasts as the polygonal morphology, the
formation of calcium phosphate salts, the production of al-
kaline phosphatase, the formation of calcium phosphate
salts, or the production of osteocalcin when these cells are
cultured with vitamin D3.
15–18
Titanium particles
Commercially pure Ti particles (−325 mesh) purchased
from Sigma-Aldrich Chemicals (Milwaukee, WI) were ster-
ilized by autoclave at 135°C for 15 min. A semiautomatic
image processing (NIH image software) of particles using
optical microscopy allowed us to determine that 80% of the
particles had a diameter smaller than 5 mm (diameter ranged
from 0.1 to 50 mm). After sterilization of the Ti particles,
culture medium was added, followed by ultrasonication for
30 min immediately before use to minimize particulate ag-
gregation. A 1% (wt %) suspension as well as appropriate
dilutions of Ti particles in medium described under “Cells”
were used in the experiments with cells.
TNF-a
Recombinant human TNF-a was purchased from Sigma
(St. Louis, MO). The range of concentrations used (0–100
ng/mL) was based on previous reports19–23 and preliminary
experiments in which TNF-a concentrated at less than 0.1
ng/mL showed little effect on the proliferation of the osteo-
blast-like cells.
Proliferation assay
Alliquots (50 mL) of MG-63 and SaOS-2 cell suspensions (5
× 104/mL and 8 × 104/mL, respectively), were seeded onto
a 96-well plate, followed by incubation for 24 h. Fifty micro-
liters of variously concentrated TNF-a (for a final concen-
tration of 0.1, 1, 10, 25, or 100 ng/mL) or 25 mL of TNF-a and
25 mL of Ti particle solution (for a final solution of 0.004,
0.016, 0.063, 0.250% for MG-63 and 0.001, 0.004, 0.016, 0.063%
for SaOS-2) were added and the culture was incubated for 72
h. For the experiments performed without Ti particles, the
control group was the cells cultured without TNF-a,
whereas for the experiments performed simultaneously
with TNF-a and Ti particles, the control group was the cells
cultured without Ti particles. Cell proliferation was deter-
mined by a CellTiter 96® Aqueous One Solution Cell Pro-
liferation Assay (Promega, Madison, WI).24 In this assay, a
tetrazolium salt is converted into a formazane product,
which is directly correlated with an absorbance reading at
520 nm. The cell proliferation (%) was defined by the absor-
bance of the supernatant of cells treated with Ti and/or
TNF-a divided by the absorbance of the supernatant of cells
not treated with Ti or TNF-a (×100). All results shown are
one of the representative outcomes from at least four experi-
ments with six replicates.
ALP activity
ALP activity was determined using an ALP kit (Diagnos-
tic kit 245; Sigma) Because the levels of ALP in MG-63 cells
are extremely low, only SaOS-2 cells were used. Cells were
plated at 5 × 104 cells/well in 24-well culture plates with
0.5-mL complete medium [medium described under “Cells”
supplemented with 50 mg/mL ascorbic acid (Sigma) and 10
mM b-glycerophosphate (Sigma)]. After 48 h, the culture
medium was replaced by fresh medium with or without 25
ng/mL TNF-a and/or 0.032% Ti particles. The control
group was defined by the cells cultured without TNF-a and
Ti particles. The cells were cultured for another 48 h, then
the medium was removed and the cells were rinsed three
times with phosphate buffered solution followed by the ad-
dition of 0.5-mL Triton-X 100 (1%). After freezing and thaw-
ing, the cell lysates were sonicated for 1 min on ice. The cell
lysates was centrifuged and a volume of 20 mL of each
sample was added to 100 mL of p-nitrophenyl phosphate
solution within a 96-well plate at 25°C and reacted for 3 min.
p-Nitrophenol is produced in the presence of ALP and the
absorbance was measured at 405 nm. The change in rate of
absorbance is directly propotional to the ALP activity. Data
were normalized for total cell protein measured with a com-
mercial kit (DC protein assay kit; BioRad, Hercules, CA).
IL-6 production
IL-6 was assayed using an ELISA kit (Predicta IL-6 kit;
Genzyme, Cambridge, MA). Cells were plated at 5 × 104
cells/well in a 24-well culture dish. After 48 h, the culture
medium was replaced by fresh media with or without 25
ng/mL TNF-a and/or 0.125 or 0.032% Ti particles for MG-63
cells and SaOS-2 cells, respectively. The control group was
the cells cultured without TNF-a and Ti particles. The cells
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were cultured for another 48 h, then the medium was col-
lected, centrifuged, and the levels of IL-6 determined. Data
were normalized for total cell protein determined as de-
scribed above.
Statistical analysis
Data are expressed as the mean ± SEM. For the prolifera-
tion assays, a one-way analysis of variance (ANOVA) test
was used to analyze the mean variance of cell proliferation.
If significant differences were found, a Student’s t test was
performed to determine which mean was different than
mean of control. For the ALP and IL-6 assays, a two-way
ANOVA test was used to analyze the effect of TNF-a, Ti
particles, and the possible additive effect of both. A 95%
confidence level was selected to define significance for all
statistical tests.
RESULTS
Particle-free medium test
The 1% Ti particle solution (without cells) was in-
cubated for 72 h, aspirated, and added (without par-
ticles) to cells. The cells cultured with this conditioned,
particle-free medium had no effect on cell prolifera-
tion and the production of ALP IL-6 (data not shown).
This excluded the possibility that Ti ions or soluble
contaminants on the surface of particles could affect
the cell functions.
Cell proliferation
Preliminary results showed that MG-63 and SaOS-2
cell proliferations were directly correlated with the ab-
sorbance values of the formazane product at 520 nm
(R2 = 0.984 and 0.987 respectively, n = 6). The absor-
bance values at 520 nm also correlated with the num-
ber of living cells, which were counted directly on a
hemocytometer with trypan blue after co-culture with
titanium particles (up to 1.0%) and/or TNF-a (up to
100 ng/mL) for 72 h (data not shown).
Effect of TNF-a on cell proliferation
Cell proliferation was statistically decreased by
TNF-a concentrated at more than 0.1 ng/mL for MG-
63 (Fig. 1(a); p < 0.05) and more than 10 ng/mL for
SaOS-2 (Fig. 1(b); p < 0.05) for 72 h. All values were
normalized by the control, TNF-a-free, group.
Effect of TNF-a on cell proliferation in the
presence of Ti particles
Ti particles concentrated at 0.063% or more for MG-
63 [Fig. 2(A)] and at 0.016% or more for SaOS-2 [Fig.
2(b)] statistically decreased the cell proliferation (p <
0.05, for Fig. 2(a,b). The sensitivity of Ti particles was
seen more in the proliferation of SaOS-2 than MG-63
cells. The addition of TNF-a concentrated at 25 ng/mL
markedly increased this adverse effect induced by
particles. Furthermore, the ratio of the inhibitory effect
caused by TNF-a, when compared with the TNF-a-
negative group, increased as the concentration of the
titanium particles increased; e.g., although 22% of the
proliferation was decreased by TNF-a at 0 wt % of Ti
particles, 36% of the proliferation was decreased by
TNF-a in the presence of 0.250 wt % of Ti particles in
Figure 1. The effect of TNF-a on osteoblast like cells after
72 h of incubation. (a) MG-63 cells, (b) SaOS-2 cells, treated
with various concentrations of TNF-a (0, 0.1, 1, 10, and 100
ng/mL). The results of proliferation versus concentration of
TNF-a were plotted (mean ± SEM, n = 6). The data were
normalized with respect to the control group (0 ng/mL
TNF-a). *p < 0.05 compared with control.
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the MG-63 cell system [Fig. 2(a)]. In the SaOS-2 cell
system [Fig. 2(b)], 77% of the proliferation was de-
creased by TNF-a in the presence of 0.063 wt % of Ti
particles, whereas 16% of the proliferation was de-
creased by TNF-a at 0 wt % of Ti particles.
Effect of TNF-a and Ti particles on ALP activity
ALP activity of SaOS-2 cells decreased when incu-
bated with TNF-a concentrated at 25 ng/mL. The
combination of TNF-a and Ti particles (0.032%) mark-
edly decreased the ALP activity of SaOS-2 cells (Fig.
3). This additive effect of TNF-a and Ti particles was
significantly relevant.
Effect of TNF-a and Ti particles on IL-6 production
IL-6 production by MG-63 cells cultured with
TNF-a markedly increased when compared with the
control (Table I). A statistically synergistic effect on
IL-6 production by the MG-63 cells was measured
when these cells were incubated with a combination of
Ti particles and TNF-a. IL-6 production from SaOS-2
cells was only detected when incubated with TNF-a.
However, Ti particles with TNF-a markedly increased
the production of IL-6 by SaOS-2 cells.
DISCUSSION
Prostheses made of titanium alloys are extensively
used for the management of joint disorders. Although
in vitro studies have revealed that Ti particles are less
toxic than Co–Cr particles,25,26 titanium alloys have a
certain premature failure rate27,28 suggesting that de-
bris from titanium prostheses have harmful effects.
One of the reasons for this may be the higher concen-
tration of metal particles in tissue around loose tita-
nium-alloy implants compared with those with loose
implants made of other alloys.29–32 In our laboratory,
we also found that Ti particles have harmful effects on
the viability of neonatal rat calvarial osteoblasts in a
dose-dependent manner.33
In the present study, we investigated the in vitro
effect of TNF-a on osteoblast functions in combination
with Ti particles at concentrations representative of
what can be found during biopsy studies.30 We have
demonstrated that TNF-a and Ti particles have addi-
tive effects on inhibition of cell proliferation and de-
crease the production of ALP on human osteogenic
cell-lines MG-63 and SaOS-2. Moreover, the produc-
tion of IL-6, which is well known to induce osteoclas-
togenesis and to directly stimulate bone resorp-
Figure 2. The effect of Ti particles and TNF-a on osteo-
blast-like cell proliferation after 72 h of incubation (mean ±
SEM, n = 6). The data were normalized with respect to the
proliferation obtained without Ti particle and TNF-a. (a)
MG-63 cells, (b) SaOS-2 cells. The concentrations of Ti par-
ticle (wt %) used in the system are indicated on the horizon-
tal axis. *p < 0.05 compared with control (without particles)
in each group.
Figure 3. The effect of Ti particles (0.032%) and TNF-a (25
ng/mL) to ALP activity on SaOS-2 cells after 48 h of incu-
bation (mean ± SEM). “+” indicates the presence of corre-
sponding stimulus, whereas “–” indicates its absence. Using
a two-way ANOVA analysis, an additive effect of TNF-a
and Ti particles on the ALP activity was demonstrated (*p <
0.001; **p < 0.042; n = 3).
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tion,20,34,35 was additively stimulated. In vitro studies
aiming to quantify the reaction of bone cells to par-
ticles should then also be concerned with the possible
modulation by cytokines that would be present in the
corresponding in vivo situation.
The data obtained with TNF-a are consistent with
several other reports in which TNF-a inhibits ALP
production but increases IL-6 synthesis in osteoblastic
cells.21–23 It has been suggested that TNF-a stimulates
IL-6 production of osteoblastic cells by activation of
transcription factor NF-kB: gene regulatory factor.23,36
It has also been reported that TNF-a regulates IL-6
production of osteoblastic cells through sphingomy-
elin hydrolysis to produce sphingosine 1-phosphate as
a second messenger and protein kinase C activation as
an autoregulator.21
In a previous study, Chiba et al.19 showed that an
approximately 5-mm3 interface membrane retrieved
from patients with loose cementless hip prostheses
cultured with 2 mL of medium produced up to more
than 9 ng TNF-a per g of tissue in the culture medium.
This concentration of TNF-a in the medium could be
concentrated more in loco. Furthermore, the concentra-
tion of TNF-a up to 100 ng/mL used in the present
study is similar to what has been used in previous
reports in which the effect of TNF-a on the functions
of the osteoblast-like cells was investigated.20–23
Using calcium phosphate cement particles and
TNF-a at concentrations similar to the present study,
no additive effect on viability was noted with osteo-
blasts obtained from neonatal Sprague-Dawley cal-
varial rat.37 Despite comparisons between results ob-
tained with different cell lines, it could be assumed
that viability of SaOS-2 and MG-63 cells would not be
affected by Ti particles and TNF-a at the concentra-
tions used in this study.
In conclusion, we showed that by combining TNF-a
and Ti particles, the effects on osteoblastic cells in
terms of decreased proliferation and ALP production,
and increased IL-6 production, are additively en-
hanced. It could be hypothesized from these results
that the exposure of osteoblasts to TNF-a in combina-
tion with Ti particles could contribute to the patho-
genesis of peri-implant osteolysis. Further in vivo in-
vestigations to clarify this hypothesis should be per-
formed.
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